Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2026-05-24 @ 9:45 AM
Study NCT ID:
NCT01938833
Status:
TERMINATED
Last Update Posted:
2025-05-16
First Post:
2013-09-05
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
13C.387
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |